| |
|
|
| |
Sector: BioTechnology
Industry: Electro-catalyst
media |
(NASD OTCBB:
PLBI) |
 |
| |
Corporate
Overview:
Proton Laboratories is a BioTech-focused
company specializing in the development and marketing of
industrial, environmental and residential systems and applications
that alter the properties of water to produce Functional
Water. The process that is utilized to accomplish this
is electrolysis with electrolyte separation. Based upon
the new science, engineering, product design and products
that have been successfully developed by our Japanese counterparts,
the Company will expand its current marketing efforts of
this concept in the North American markets and with future
expansion to a European market.
Functional electrolyzed water has been
studied and used in Japan for the past 46 years and the
Japanese have become world experts in this technology.
All systems that are imported by the Company are of the
highest level of design, engineering, safety, reliability
and user friendliness. The Company and its core advisory
members have invested considerable resources during the
past 10-year period to fully understand the technology,
science, market implications and the far-reaching benefits
that are gained from the use of Functional Electrolyzed
Water.
Proton Laboratories is in possession
of an array of applications that ensure food safety,
address microbial concerns, provide non-chemical agricultural
medium, provide medical-grade sterilization, structure
safe and healthy drinking water, and provide a cache
of industry-related uses of a highly-efficacious and
safe medium.
The premise on which Functional Electrolyzed
Water derives its efficacies are from the process-induced
changes in pH, Oxidation Reduction Potential (ORP), Dissolved
Oxygen (DO) and energy measured in levels of ionic potential
(IP) of the water. The restructuring process alters these
parameters to create a water medium that is highly effective
in obtaining desired functional results in many critical
applications.
Proton Laboratories possesses the technology,
science, hardware and marketing experience to make the
use of Functional Electrolyzed Water acceptable in North
America. The following chart shows a small sampling of
the efficacy of Functional Electrolyzed Water.
|
BACTERIAL
STRAIN |
BACTERIAL
LOAD |
Contact
Time |
10 Seconds |
60 Seconds |
300 Seconds |
| P. aeruginosa |
6.1x107 |
<100 |
<100 |
<100 |
| E.coli O157:H7 |
3.1x107 |
<100 |
<100 |
<100 |
| S.sonnei |
1.7x106 |
<100 |
<100 |
<100 |
| S.enteridis |
1.7x108 |
<100 |
<100 |
<100 |
| V.parahaemoluticus |
8.3x107 |
<100 |
<100 |
<100 |
| MRSA |
1.7x106 |
<100 |
<100 |
<100 |
| S.pyogenes |
3.2x107 |
<100 |
<100 |
<100 |
| B.subtilis |
4.0x107 |
not tested |
2.6x103 |
<100 |
| C.botulinum |
8.1x106 |
2.6x103 |
<100 |
<100 |
|
Meets European efficacy
standards in accordance with standard EN 1040 |
| |
The benefits of Functional
Electrolyzed Water are in its high rate of efficacy, safety
to the worker and environment, non-ability of microbes
to develop an immunity against its kill factor and cost
efficiency. It promotes a new paradigm in our thinking
for a wide array of industrial and medical challenges.
Proton Laboratories also possesses a repertoire of proprietary
processes and products, formulated with Functional Electrolyzed
Water, which deliver exponentially-empowered efficacies
of solutions needed in the maintenance of health and wellness.
Sector Overview:
Current microbial control and containment processes
and barometers utilized in industry are processes that
have been relied upon for generations. As more and more
complexities arise in safety and containment procedures,
greater challenges are placed towards the scientific
communities for new modalities that will counter these
new challenges. Quite often, new modalities are based
upon existing processes or media with inherent restrictions
placed upon its level of efficacy, sustainability or
evolutionary capabilities.
Functional Electrolyzed Water, a byproduct
based upon a process of electrolyte separation and restructuring,
provides a refreshingly new, natural-based medium, that
is superior to many of the current modalities utilized
in the areas of microbial and viral control.
Today, there are frequent instances
in which bacteria have caused massive and costly recalls
to industry based upon bacterial strains such as E.coli,
Salmonella and Lysteria. In the hospital environments,
numerous situations of MRSA or Staph infections have
caused ongoing concerns to the safety and welfare of
hospital patients and caregivers. Functional Electrolyzed
Water provides a highly-efficacious medium to control
and eradicate these concerns, at a minimal cost, while
creating economic dividends resulting from the areas
of microbial safety, potentially lower health care costs
and insurance premiums. The reassurance in the ability
of maintaining the economic viability of an organization
or institution from reliable and efficacious, microbe-free
environments and products cannot be underestimated.
Significant Transactions:
Proton Laboratories has obtained Exclusive or
OEM Distribution Agreements from electrolysis manufacturers
such as OSG Corporation of Japan, Kyushu Matsushita Electric
of Japan, and Solutions Technos Ltd. Company of Japan.
The Company has also obtained a Licensing Agreement from
Bio-Redox Laboratory of Japan to provide the company
with unique nutraceutical products, processes and applications.
In addition to these product distribution
agreements, the Company has long-term working relationships
with key scientific, academic, industrial, governmental
and trade organizations in Japan. The Company is considered
a true pioneer in the introduction of this unique and
highly-promising technology to industrial markets in
North America.
|
| |
Add-on
Acquisition; Roll-up
As the Company builds upon a solid revenue stream,
based upon its current products and licensing concepts,
the Company will evaluate the need for synergistic mergers
or friendly acquisitions of niche distribution companies
who are currently and actively marketing products or services
to an industry that we will expand in.
When the Company is at a point where
products based upon Functional Electrolyzed Water become
ready for market, as viable nutriceutical products, Proton
Laboratories will seek for acquisition a niche, natural
products-based nutriceutical company for production and
distribution of our products.
Additional Growth:
The Company will establish local offices in Canada
and Mexico. It is planned that subsidiaries of Proton
Laboratories will be created in these markets with the
company name Proton Laboratories Canada/Mexico.
In order to increase distribution of
our products into key strategic industries, various forms
of joint ventures, strategic alliances, licensing agreements
and private-labeling distribution rights will be provided
to competent business partners.
Also, in order for us to be able to
maximize our market potentials, new market-driven applications
will be continually developed over the next 5 years.
Currently, the Company is in possession of a diversified
array of proprietary applications, for which markets
will be created. The Company plans on introducing 2 new
applications on a yearly basis, which will perpetually
add to the market and revenue base of the company.
Investment Highlights:
- A new and promising technology that has been market
pioneered by the Company’s core group of specialists
for the past 10 years - necessary infrastructure is
identified and market readied.
- Strength of the Company is in its extensive knowledge
of market-proven applications backed with sound manufacturing
support from Japan.
- Exclusive, proprietary, trade-secret processes and
formulations based upon Functional Electrolyzed Water.
- Company will build its market presence in a logical,
non-constraining and long-term manner with ongoing
revenue and profit growth.
|
Corporate
Address: |
|
1135 Atlantic Avenue,
Suite 101
Alameda, California 94501
Tel: (510) 865-6412
Fax: (510) 865-9385 |
Oregon Office: |
333 SE Second Avenue
Portland, Oregon 97214
Email: glt@mooreco.com
Tel: (503) 736-2504
Fax: (503) 232-7447 |
Washington State Office: |
1115 South Central Ave
Quincy, Washington 98848
Email: cghalterman@msn.com
Tel: (509) 237-1534
Fax: (509) 931-3238 |
Chairman and CEO: |
Edward E. Alexander
California Office |
Director, President: |
Gary A. Taylor
Portland Office |
VP of Technology Integration: |
Carl Halterman
Washington Office |
VP of Technology: |
Mr. H. Tanaka
California Office |
CFO: |
Edward E. Alexander
California Office |
Director of Asian Sales: |
Jean Wang |
Director of New Business
Development: |
Edward E. Alexander |
Operations Manager: |
Victor Miranda |
Scientific Adviser: |
G. Fernandes Ph.D. |
Scientific Adviser: |
K. Hanaoka Ph.D. |
CPA: |
T.G. Johnson & Associates C.P.A.
Oakland, California |
Corporate Auditor: |
Hansen, Barnett and Maxwell
Salt Lake City, Utah |
Legal Counsel: |
Joel Seidner Esq.
Houston, Texas |
Sector Comps: |
Hoshizaki Company
Miox International
Electric Aquagenics Unlimited |
|
| |
 |
| |
| Note
regarding FORWARD LOOKING STATEMENTS: All statements other
than the statements of historical facts included in this
overview, including without limitation, statements regarding
our future financial position, business strategy, projected
costs and plans, objectives of our management for future
operations and pro forma, as adjusted and as further adjusted
financial data, are forward looking statements. In addition,
forward-looking statements can be identified by the use
of forward looking terminology such as “may”, “will”, “proposed”, “expect”, “intend”, “estimate”, “anticipate”, “believe”,
or “continue” or the negative thereof, variations
thereon or similar terminology. Although we believe that
the expectations reflected in such forward-looking statements
are reasonable, we cannot assure you that such results,
performance or achievements to be materially different
from our forward-looking statements. Also, subsequent written
and oral forward-looking statements attributable to our
Company, or persons acting on any of their behalf, are
expressly qualified in their entirety by the cautionary
statements. We caution you not to place undue reliance
on these forward-looking statements, which speak only as
of the present document. |
| |
 |
| |
|
|
|
|
 |
 |
|
|